Skip to main content
SpringerLink
Log in

Cellular microcytotoxicity in a human bladder cancer system: Analysis of in vitro lymphocyte-mediated cytotoxicity against cultured target cells

  • Original Papers
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

The microcytotoxicity test (MCT) has been used to determine the cytotoxic effects of purified peripheral blood lymphocytes from patients with carcinoma of the urinary bladder (BT), tumor control patients (TC) (tested after therapy), and healthy donors (HD) against cultured bladder tumor cells, melanoma cells, and normal bladder cells. Lymphocytes from all three donor groups were tested in parallel. Disease-specific cytotoxicity (CTX) is defined as statistically significant and selective destruction of disease-related tumor target cells by the test lymphocytes in comparison with the baseline controls. Nonspecific CTX is defined as statistically significant destruction of a proportion (selective) or all (nonselective) disease unrelated target cells by the effector cells.

Within the different donor groups, an enormous variation in non-disease related cytotoxic effects against the different cell lines was seen. It appeared that the selection of the baseline control influences the level of CTX and the specificity of the reaction.

In order to determine whether a disease-specific cytotoxic effect was superimposed on the nonspecific cytotoxicity, the overall cytotoxic effects of the lymphocytes from the BT, TC patients and HD were compared statistically. The analysis of results revealed that effector cells from BT, TC patients and HD showed the same pattern of reactivity, but the CTX of lymphocytes from BT patients tested before therapy was stronger in comparison with the CTX of lymphocytes from the same group of BT patients after therapy and in comparison with the CTX of lymphocytes from HD and TC patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Baldwin, R. W.: Immunological aspects of chemical carcinogenesis. Adv. Cancer Res. 18, 1–75 (1973)

    Google Scholar 

  2. Baldwin, R. W.: In vitro assays of cell-mediated immunity to human solid tumors: problems of quantitation, specificity and interpretation. J. Nat. Cancer Inst. 55, 745–748 (1975)

    Google Scholar 

  3. Baldwin, R., Embleton, M. J.: New antigens on spontaneous and carcinogen induced rat tumours defined by in vitro lymphocytotoxicity assays. Int. J. Cancer 13, 433–443 (1974)

    Google Scholar 

  4. Baldwin, R. W., Embleton, M. J., Jones, J. S. P., Langman, M. J. S.: Cell-mediated and humoral immune reactions to human tumours. Int. J. Cancer 12, 73–83 (1973)

    Google Scholar 

  5. Baldwin, R. W., Price, M. R., Robins, R. A.: Inhibition of hepatoma immune lymph node cell cytotoxicity by tumour bearer serum and solubilized hepatoma antigens. Int. J. Cancer 11, 527–535 (1971)

    Google Scholar 

  6. Bean, M. A., Bloom, B. R., Herberman, R. B., Old, L. J., Oettgen, H. F., Klein, G., Terry, W. B.: Cell-mediated cytotoxicity for bladder carcinoma: evaluation of a workshop. Cancer Res. 35, 2902–2913 (1975)

    Google Scholar 

  7. Bean, M. A., Pees, H., Fogh, J. E., Grabstald, H., Oettgen, H. F.: Cytotoxicity of lymphocytes from patients with cancer of the urinary bladder: detection by a 3H-proline microcytotoxicity test. Int. J. Cancer 14, 186–195 (1974)

    Google Scholar 

  8. Bean, M. A., Pees, H., Rosen, G., Oettgen, H. F.: Prelabelling target cells with 3H-proline as a method for studying lymphocyte cytotoxicity. Nat. Cancer Inst. Mongr. 37, 41–48 (1973)

    Google Scholar 

  9. Berkelhammer, J., Mastrangelo, M. J., Lancius, J. F., Bodwitha, A. J., Prehn, R.: Sequential in vitro reactivity of lymphocytes from melanoma patients receiving immunotherapy compared with the reactivity of lymphocytes from healthy donors. Int. J. Cancer 16, 571–578 (1975)

    Google Scholar 

  10. Boyle, W.: An extension of the 51Cr-release assay for the estimation of mouse cytotoxins. Transplantation 6, 761–764 (1968)

    Google Scholar 

  11. Bubenik, J., Jakoubková, J., Krákora, P., Baresová, M., Helbich, P., Viklický, V., Malasková, V.: Cellular immunity to renal carcinomas in man. Int. J. Cancer 8, 503–513 (1971)

    Google Scholar 

  12. Bubeník, J., Perlmann, P., Helmstein, K., Moberger, G.: Cellular and humoral immune responses to urinary bladder carcinomas. Int. J. Cancer 5, 310–319 (1970)

    Google Scholar 

  13. De Vries, J. E., Cornain, S., Rümke, P.: Cytotoxicity of non-T versus T-lymphocytes from melanoma patients and healthy donors on short- and long-term cultured melanoma cells. Int. J. Cancer 14, 427–434 (1974)

    Google Scholar 

  14. De Vries, J. E., Meyering, M., van Dongen, A., Rümke, P.: The influence of different isolation procedures and the use of target cells from melanoma cell lines and short-term cultures on the non-specific cytotoxic effects of lymphocytes from healthy donors. Int. J. Cancer 15, 391–400 (1975)

    Google Scholar 

  15. De Vries, J., Rümke, P., Bernheim, J. L.: Cytotoxic lymphocytes in melanoma patients. Int. J. Cancer 9, 567–576 (1972)

    PubMed  Google Scholar 

  16. De Vries, J. E., Rümke, P.: Tumour-associated lymphocyte cytotoxicity superimposed on “spontaneous” cytotoxicity in melanoma patients. Int. J. Cancer 17, 182–190 (1976)

    Google Scholar 

  17. Fossati, G., Canevaki, S., Della Porta, G., Balzarini, G. P., Veronesi, U.: Cellular immunity to human breast carcinoma. Int. J. Cancer 10, 391–396 (1972)

    Google Scholar 

  18. Fossati, G., Colnaghi, M. I., Della Porta, G., Cascinelli, N., Veronesi, U.: Cellular and humoral immunity against human malignant melanoma. Int. J. Cancer 8, 344–350 (1971)

    CAS  PubMed  Google Scholar 

  19. Greenberg, A. H., Playfair, J. V. L.: Spontaneously arising cytotoxicity to the P-815-X mastocytoma in NZB mice. Clin. exp. Immunol. 16, 99–110 (1974)

    Google Scholar 

  20. Hellström, I., Hellström, K. E.: Some recent studies on cellular immunity to melanomas. Fed. Proc. 32, 156–159 (1973)

    Google Scholar 

  21. Hellström, K. E., Hellström, I.: Cellular immunity against tumor antigens. Adv. Cancer Res. 12, 167–223 (1969)

    Google Scholar 

  22. Hellström, K. E., Hellström, I.: Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens. Adv. Immunol. 18, 209–277 (1974)

    Google Scholar 

  23. Hellström, I., Hellström, K. E., Sjögren, H. O., Warner, G. A.: Demonstration of cell-mediated immunity to human neoplasma of various histological types. Int. J. Cancer 7, 1–16 (1971)

    PubMed  Google Scholar 

  24. Heppner, G., Henry, E., Stolbach, L., Cummings, F., McDonough, E., Calabresi, P.: Problems in the clinical use of the microcytotoxicity assay for measuring cell-mediated immunity to tumor cells. Cancer Res. 35, 1931–1937 (1975)

    CAS  PubMed  Google Scholar 

  25. Heppner, G. H., Stolbach, L., Byrne, M., Cummings, F. J., McDonough, E., Calabresi, P.: Cell-mediated reactivity to tumor antigens in patients with malignant melanoma. Int. J. Cancer 11, 245–260 (1973)

    CAS  PubMed  Google Scholar 

  26. Herberman, B., Oldham, R. K.: Problems associated with study of cell-mediated immunity to human tumors by microcytotoxicity assays. J. Nat. Cancer Inst. 55, 749–753 (1975)

    Google Scholar 

  27. Hersey, D. S.: Specificity of cell-mediated cytotoxicity against human melanoma lines: Evidence of “non-specific” killing by activated T-cells. Int. J. Cancer 16, 173–183 (1975a)

    CAS  PubMed  Google Scholar 

  28. Hersey, D. S., Edwards, J., Edwards, A., Adams, E., Kearny, R., Milton, G. W.: Comparison of 51Cr release and microcytotoxicity assays against human melanoma cells. Int. J. Cancer 16, 164–172 (1975b)

    Google Scholar 

  29. Jondal, M., Pross, H.: Surface markers on human B and T lymphocytes. VI. Cytotoxicity against cell lines as a functional marker for lymphocyte subpopulations. Int. J. Cancer 15, 596–605 (1975)

    CAS  PubMed  Google Scholar 

  30. Kay, D. H., Sinkovics, J. C.: Cytotoxic lymphocytes from normal donors. Lancet 2, 296 (1974)

    Google Scholar 

  31. Kiessling, R., Klein, E., Wigzell, H.: “Natural” killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur. J. Immunol. 5, 112–117 (1975a)

    Google Scholar 

  32. Kiessling, R., Petrányi, G., Klein, G., Wigzell, H.: Genetic variation of in vitro cytolytic activity and in vivo rejection potential of non-immunized semi-syngeneic mice against a mouse lymphoma line. Int. J. Cancer 15, 933–940 (1975b)

    Google Scholar 

  33. Mukherji, B., Vassos, D., Flowers, A., Binder, S. C., Nathanson, L.: Selective and non-selective lymphocytotoxicity in human melanoma: observation on the effect of long-term culture and fetal bovine serum on target-cell sensitivity to lymphocytes. Int. J. Cancer 16, 971–980 (1975a)

    Google Scholar 

  34. Mukherji, B., Vassos, D., Flowers, A., Binder, S., Nathanson, L.: Variables and specificity of in vitro lymphocyte mediated cytotoxicity in human melanoma. Cancer Res. 35, 3721–3730 (1975b)

    Google Scholar 

  35. Nunn, M. E., Djeu, J., Lavrin, D. et al.: Natural cytotoxicity reactivity of rat lymphocytes against syngeneic Gross leukemia. Proc. Amer. Assoc. Cancer Res. 14, 87 (1973)

    Google Scholar 

  36. Oldham, R. K., Djeu, J. Y., Cannon, G. B., Siwarshi, D., Herberman, R. B.: Cellular microcytotoxicity in human tumor systems: analysis of results. J. Nat. Cancer Inst. 55, 1309–1318 (1975)

    Google Scholar 

  37. Oldham, R. K., Siwarski, D., McCoy, J. L. et al.: Evaluation of a cell-mediated cytotoxicity assay utilizing 125iododeoxyuridine-labelled tissue-culture target cells. Nat. Cancer Inst. Monogr. 37, 49–58 (1973)

    Google Scholar 

  38. O'Toole, C.: Standardisation of microcytotoxicity assay for cell-mediated immunity. Nat. Cancer Inst. Mongr. 37, 19–24 (1973)

    Google Scholar 

  39. O'Toole, C., Perlmann, P., Wigzell, H., Unsgaard, B., Setterlund, C. G.: Lancet 1, 1085–1089 (1973)

    Google Scholar 

  40. O'Toole, C., Perlmann, P., Unsgaard, B., Moberger, G., Edsmyr, F.: Cellular immunity to human urinary bladder carcinoma. I. Correlation to clinical stage and radiotherapy. Int. J. Cancer 10, 77–91 (1972)

    CAS  PubMed  Google Scholar 

  41. O'Toole, C., Stjskal, V., Perlmann, P. et al.: Lymphoid cells mediating tumor-specific cytotoxicity to urinary bladder. J. Expt. Med. 139, 457–466 (1974)

    Google Scholar 

  42. Pierce, G. E., Devald, B.: Microcytotoxicity assays of tumor immunity in patients with bronchogenic carcinoma correlated with clinical status. Cancer. Res. 35, 3577–3583 (1975)

    Google Scholar 

  43. Rosenberg, E. B., McCoy, J. L., Green, S. S., Donnelly, F. C., Siwarsky, D. F., Levine, P. H., Herberman, R. D.: Destruction of human lymphoid tissue culture cell lines by human peripheral lymphocytes in 51Cr-release cellular cytotoxicity assays. J. Nat. Cancer Inst. 52, 345–352 (1974)

    Google Scholar 

  44. Skurzak, H., Steiner, L., Klein, E., Lamon, E.: Cytotoxicity of human peripheral lymphocytes ganglioma, osteosarcoma and glia cell lines. Nat. Cancer Inst. Monogr. 37, 93–102 (1973)

    Google Scholar 

  45. Takasugi, M., Klein, E.: A micro-assay for cell-mdited immunity. Transplantation 9, 219–227 (1970)

    CAS  PubMed  Google Scholar 

  46. Takasugi, M., Mickey, M. R., Terasaki, P. I.: Reactivity of lymphocytes from normal persons on cultured tumor cells. Cancer Res. 33, 2898–2902 (1973)

    CAS  PubMed  Google Scholar 

  47. Takasugi, M., Mickey, M. R., Terasaki, P. I.: Studies on specificity of cell-mediated immunity to human tumors. J. Nat. Cancer Inst. 53, 1527–1538 (1974)

    Google Scholar 

  48. Vogelenzang, A. A., Compeer-Deliker, G.: Elimination of mycoplasma from various cell cultures. Antoni van Leeuwenhoek 35, 1027–1036 (1969)

    Google Scholar 

  49. Zarling, J. M., Nowinsky, R. C., Bach, F. H.: Lysis of leukemia cells by spleen cells of normal mice. Proc. Nat. Acad. Sci. USA 72, 7, 2780–2784 (1975)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Rotterdam Radio-Therapy Institute, Groene Hilledijk 301, Rotterdam-24, The Netherlands

    Reinier L. H. Bolhuis

  2. Radiobiological Institute TNO, Lange Kleiweg 151, Rijswijk, The Netherlands

    Reinier L. H. Bolhuis

Authors
  1. Reinier L. H. Bolhuis
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bolhuis, R.L.H. Cellular microcytotoxicity in a human bladder cancer system: Analysis of in vitro lymphocyte-mediated cytotoxicity against cultured target cells. Cancer Immunol Immunother 2, 245–256 (1977). https://doi.org/10.1007/BF00206006

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00206006

Keywords

Search

Navigation